03:33 PM EST - ProMetic Life Sciences Inc. : announced today that its expanded partnership with Wuhan Institute of Biologic Products and its parent company CNBG has resulted in the successful completion of the first set of milestones associated with the scaling up of the plasma protein purification system (PPPS™) manufacturing platform in CNBG's wuhan facility. ProMetic Life Sciences Inc.
shares T.PLI are trading up $0.055 at $0.16.
